Company profile: ivWatch
1.1 - Company Overview
Company description
- Provider of intravenous infiltration detection solutions, including the ivWatch Monitoring System that continuously monitors peripheral IVs to detect infiltrations and extravasations early with real-time notifications to clinicians; SmartTouch single-use sensor and reusable optical fiber sensor for flexible, comfortable, MRI-compatible IV site monitoring; and OEM solutions to embed the technology into patient monitors or infusion pumps.
Products and services
- IvWatch Monitoring System: A self-contained unit that continuously surveils peripheral IV status to detect infiltrations and extravasations early, delivering real-time clinician notifications via an electronic device and attached skin sensor
- OEM Solutions: Embedded integration systems enabling ivWatch’s IV infiltration detection to be incorporated into existing patient monitoring systems or infusion pumps for broader platform-level capability
- SmartTouch Sensor: A single-use sensor that connects to a reusable patient cable, architected for flexible, comfortable IV site monitoring, particularly for small or active patients.
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to ivWatch
SIS Medical
HQ: Switzerland
Website
- Description: Provider of vascular disease treatment products, developed, produced, and sold through its subsidiaries; founded in 2005 and headquartered in Winterthur, Switzerland.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full SIS Medical company profile →
CHF Solutions
HQ: United States
Website
- Description: Provider of innovative cardiac care medical devices, designing and manufacturing a device that removes excess fluid from patients with fluid overload, offering practical solutions to address unmet clinical needs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CHF Solutions company profile →
Corvia Medical
HQ: United States
Website
- Description: Provider of transcatheter structural heart devices for heart failure, including the Corvia Atrial Shunt (InterAtrial Shunt Device) designed to treat diastolic heart failure/HFpEF by reducing pressures in the heart and lungs, supported by clinical evidence and the RESPONDER-HF clinical study assessing efficacy in patients with EF ≥40%.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Corvia Medical company profile →
ATS Medical
HQ: United States
Website
- Description: Provider of cardiovascular surgery medical devices, doing business as Medtronic ATS Medical, Inc.; manufactures, markets, and distributes mechanical heart valves (including the ATS Open Pivot Heart Valve), aortic valve graft prostheses, and other cardiovascular accessories.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ATS Medical company profile →
Farapulse
HQ: United States
Website
- Description: Provider of catheter-based pulsed field ablation tools to treat atrial fibrillation, including the FARAPULSE PFA System that selectively ablates cardiac tissue with pulsed electric fields to minimize damage to surrounding tissues; the FARAWAVE catheter for pulmonary vein isolation in paroxysmal AF; the FARADRIVE steerable sheath for percutaneous catheter introduction; and the FARASTAR generator delivering pulsed fields.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Farapulse company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for ivWatch
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to ivWatch
2.2 - Growth funds investing in similar companies to ivWatch
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for ivWatch
4.2 - Public trading comparable groups for ivWatch
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →